Pixie Dust Technologies, Inc. Announces Collaborative Research Agreement With Tohoku University School Of Medicine
Portfolio Pulse from Benzinga Newsdesk
Pixie Dust Technologies, Inc. (NASDAQ:PXDT), a Japanese technology company, has announced a joint research agreement with Tohoku University School of Medicine to develop and commercialize non-pharmaceutical skin disease treatments using wave control technology. This agreement builds on an ongoing partnership between the two entities since 2020.
October 27, 2023 | 12:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Pixie Dust Technologies' partnership with Tohoku University School of Medicine to develop non-pharmaceutical skin disease treatments could potentially open new revenue streams for the company.
The partnership with Tohoku University School of Medicine could potentially lead to the development of innovative skin disease treatments. If successful, this could open new revenue streams for Pixie Dust Technologies, which could positively impact the company's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100